Literature DB >> 2535920

Sulindac for polyposis of the colon.

W R Waddell1, G F Ganser, E J Cerise, R W Loughry.   

Abstract

The effect of sulindac, a nonsteroid antiinflammatory drug, on colon polyposis has been evaluated in seven patients after subtotal colectomy and ileoproctostomy and in four patients with intact colons. The patients all had Gardner's syndrome or familial polyposis coli. All polyps were eliminated, except for a few that arose in the rectal mucosa and the anal canal. No cancers developed in these patients on follow-up.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535920     DOI: 10.1016/0002-9610(89)90442-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  55 in total

1.  Effects of sulindac on sporadic colorectal adenomatous polyps.

Authors:  N Matsuhashi; A Nakajima; Y Fukushima; Y Yazaki; T Oka
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 2.  Chemoprevention in familial adenomatous polyposis.

Authors:  Brian Kim; Francis M Giardiello
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

Review 3.  Cyclooxygenase- and lipoxygenase-mediated DNA damage.

Authors:  N Speed; I A Blair
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

4.  Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis.

Authors:  Jennifer S Davids; Adelaide M Carothers; Beatrice C Damas; Monica M Bertagnolli
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

5.  Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study.

Authors:  N Arber; S Kuwada; M Leshno; R Sjodahl; R Hultcrantz; D Rex
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

Review 6.  Prevention and management of duodenal polyps in familial adenomatous polyposis.

Authors:  L A A Brosens; J J Keller; G J A Offerhaus; M Goggins; F M Giardiello
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

7.  Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers.

Authors:  G Morgan
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

Review 8.  Colon cancer: polyps, prevention, and politics.

Authors:  G L Eastwood
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

9.  NSAIDs and colorectal cancer prevention.

Authors:  Takeo Iwama
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

10.  Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.

Authors:  S J Shiff; L Qiao; L L Tsai; B Rigas
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.